Fisher Scientific moves from strength to strength
Thermo Fisher Scientific went through a process of intensive
integration of all its division and now intends to heavily invest in
manpower, and expand and upgrade facilities in India.
Thermo Fisher Scientific which was earlier known
in India as Thermo Electron LLS India is a wholly-owned subsidiary of
the US-based Thermo Fisher Scientific. It supplies
consumables, and analytical, scientific and laboratory instruments. The
company also offers integrated reagents to enhance integration of
laboratory workflow solutions. Thermo Fisher Scientific is a result of
the merger between Thermo Electron and Fisher Scientific in 2006.
In fiscal 2008-09, Thermo Fisher Scientific in India clocked a total
sales of Rs 504.89 crore as against Rs 315.68 crore in fiscal
2007-08. The company’s life science business in India clocked
Rs 185.79 crore in 2008-09, making up 37 percent of the overall India
revenue.Despite the economic slowdown Thermo Fisher Scientific
continued with its investments in India.
“Our growth this year can be attributed to the acquisitions
we have made, with the inauguration of the new facilities. Fisher
Scientific which is our customer channel group is still hiring people
so that we can inculcate new products from the global network into the
Indian market. In our scientific instruments division with Chemito
Technologies coming on board and the sales board fully integrated, we
are still finding new people for recruitment. We also acquired the
environmental instruments division which already had a sales force
team, who have also been incorporated into our organization,”
said Koos van der Steuijt, vice president and general manager, Thermo
The Laboratory Products Group saw a double digit growth, with
businesses coming in mainly from the government academic institutions,
clinical segments (IVF and blood banks) and the diagnostics
In November last year, Thermo Fisher Scientific opened its $10 million
facility in Ahmedabad to support growing demand for biopharma services.
The 150,000 sq.ft facility will focus on packaging, global distribution
and logistics management of tightly regulated pharmaceutical samples to
patients participating in clinical trials across the globe and
specifically in India.
“We have 250 sales people out here in the market and we need
to educate them about our products across divisions in order to become
more and more unified while presenting Thermo Fisher Scientific to the
customer. Increasingly our customers expect higher service levels from
our local organization. We are happy to accomodate that and we feel
proud of being challenged and being able to fullfil those
needs,” said Koos van der Steuijt.
Thermo Fisher Scientific has also been successful in reaching out to
even remote areas in India.